Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (β-score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (β-scor
about
Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem CellsPancreas Islet Transplantation for Patients With Type 1 Diabetes Mellitus: A Clinical Evidence ReviewDisease modifying therapies in type 1 diabetes: Where have we been, and where are we going?Single-donor islet transplantation in type 1 diabetes: patient selection and special considerations.Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.International workshop: islet transplantation without borders enabling islet transplantation in Greece with international collaboration and innovative technology.Low levels of C-peptide have clinical significance for established Type 1 diabetes.Restoration of Glucose Counterregulation by Islet Transplantation in Long-standing Type 1 DiabetesIslet transplantation from a nationally funded UK centre reaches socially deprived groups and improves metabolic outcomes.CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes.Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia.Continuous glucose monitoring analysis as predictor of islet yield and insulin requirements in autologous islet transplantation after complete pancreatectomy.Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcomeMinimal functional β-cell mass in intraportal implants that reduces glycemic variability in type 1 diabetic recipients.Validation of the BETA-2 Score: An Improved Tool to Estimate Beta Cell Function After Clinical Islet Transplantation Using a Single Fasting Blood Sample.Residual C-peptide in type 1 diabetes: what do we really know?First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 6: patient selection for pilot clinical trials of islet xenotraFall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose.Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression.Defining Outcomes for β-Cell Replacement Therapy in the Treatment of Diabetes: a Consensus Report on the Igls Criteria from the IPITA/EPITA Opinion Leaders Workshop.Integration of Routine Parameters of Glycemic Variability in a Simple Screening Method for Partial Remission in Children with Type 1 Diabetes.Applications of Variability Analysis Techniques for Continuous Glucose Monitoring Derived Time Series in Diabetic Patients
P2860
Q26752205-B6C6EDD6-4C53-4F96-B349-2B9EA0CFFA08Q26773701-8215A791-7166-4E24-BD6A-4C3447F2DFA3Q28081034-71FDEE68-CFA0-4216-873C-AD313C884367Q30252993-829935DB-77EA-40EA-9337-3FE9A84BEAE8Q31099230-B522E829-205B-4075-A5E3-C0A708C1F1C4Q33900815-2ED25110-4F58-4A25-AAE8-D18757DF54F0Q34484912-F41AC8FF-E04D-4F20-9EE9-061C29EF8EC0Q35532258-62BEFB46-AA6D-4D5D-902B-308CD309D45CQ35558403-BDEF22E3-9610-41D6-9FFD-24CCFCE3E56CQ35561483-8033C0BE-202F-4F37-BB7D-98FDC3820F9AQ35630711-972E314F-CFAF-4E62-A9B5-1066C6687204Q35682866-819806CB-D49F-4442-92C7-07557C974E86Q37088225-A6CAE310-C0E2-4990-AE2F-6382D743B486Q37277940-E2691ECC-CCC9-407C-AB03-087F9B5B4E67Q37357372-C8D8B49B-D949-483F-BCA7-B2011BCE533DQ38197230-3074ABBB-6929-47E4-9A00-DB8E7C8ABBDFQ38751293-73924AA9-F1B6-4F9F-91B7-2A728C3AABAAQ39596760-9EB559C7-7910-44EC-8202-1EF7C08C2973Q41470466-B4994F89-4ADF-47F4-8C22-C219F96D4C38Q49906467-7DF17EB3-9601-4038-B142-6F5703A97552Q55451980-D57DDA00-014A-4039-A6DC-763A53846288Q58761384-7E0D3298-EC60-412D-8EF8-B129C4515F84
P2860
Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (β-score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (β-scor
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Continuous glucose monitoring ...... ss severe hypoglycemia (β-scor
@ast
Continuous glucose monitoring ...... ss severe hypoglycemia (β-scor
@en
type
label
Continuous glucose monitoring ...... ss severe hypoglycemia (β-scor
@ast
Continuous glucose monitoring ...... ss severe hypoglycemia (β-scor
@en
prefLabel
Continuous glucose monitoring ...... ss severe hypoglycemia (β-scor
@ast
Continuous glucose monitoring ...... ss severe hypoglycemia (β-scor
@en
P2093
P2860
P50
P921
P356
P1476
Continuous glucose monitoring ...... ss severe hypoglycemia (β-scor
@en
P2093
Christian Noël
Frédérique Defrance
Julie Kerr-Conte
Laurent Arnalsteen
Marc Hazzan
Valéry Gmyr
Violeta Raverdy
P2860
P304
P356
10.1210/JC.2012-2115
P407
P577
2012-09-20T00:00:00Z